Table 1.
Analyte | Control | Infected | Obese | Obese-Infected | Reference Values |
---|---|---|---|---|---|
RBC (× 1012) | 6.4 ± 0.2 | 6.8 ± 0.2 | 6.6 ± 0.5 | 6.7 ± 0.3 | 6–6.8 [13] |
WBC (× 109) | 6.9 ± 1.3 | 7.3 ± 1.1 | 6.3 ± 1.4 | 6.6 ± 0.9 | 6.8–9.7 [13] |
Lymphocytes (%) | 44.8 ± 2.5 | 43.3 ± 4.5 | 44.7 ± 9 | 38.2 ± 3.4 | 39–67 [13] |
Eosinophils (%) | 3.5 ± 0.2 | 4.3 ± 1.1 a | 2.3 ± 1 | 1.8 ± 1.1 b | 1–2 [13] |
Neutrophils (%) | 45.3 ± 2.4 | 45.7 ± 3.6 a | 46.7 ± 9.1 a | 55.5 ± 4.2 *,b | 25–46 [13] |
Basophils (%) | 1.5 ± 1 | 1.7 ± 0.5 | 2.3 ± 1.4 | 1.3 ± 0.5 | 2.1–5 [13] |
Monocytes (%) | 4.8 ± 2.3 | 5 ± 1.3 | 4 ± 1.7 | 3.2 ± 2 | 1–8 [13] |
MCH (Pg) | 19.5 ± 0.6 | 19.6 ± 0.5 | 19.8 ± 0.8 | 19.5 ± 0.4 | 20–21 [13] |
MCHC (g/dL) | 30.5 ± 0.5 | 30.3 ± 0.5 | 30.2 ± 0.5 | 29.7 ± 0.2 | 32–34 [13] |
AST(IU/L) | 20.4 ± 5.6 | 16.4 ± 8.1 | 18.6 ± 7.8 | 19.2 ± 6.6 | 14–80 [14] |
ALT(IU/L) | 22.8 ± 3 | 20.9 ± 6.6 | 18.2 ± 4.8 | 20.6 ± 6.5 | 14–113 [14] |
Cholesterol (mg/dL) | 101.9 ± 4.5 | 88.3 ± 4.3 *,a | 103.1 ± 3.8 b | 91.3 ± 2.2 *,a | 10–80 [14] |
Triglycerides (mg/dL) | 93.6 ± 12.4 | 91.3 ± 11 a | 115.3 ± 9.9 *,b | 81.3 ± 5.7 a | 15–160 [14] |
HDL (mg/dL) | 51.04 ± 4.3 | 47.2 ± 4.5 | 52.7 ± 3.5 a | 44.2 ± 2.6 b | 46–58 [14] |
VLDL (mg/dL) | 17.8 ± 2.57 | 19.3 ± 2.8 a | 25.8 ± 3 *,b | 16.2 ± 1.1 a | 9–15 [14] |
RBC, red blood cells; WBC, White blood cells; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase. Values are expressed as mean ± SD. * Indicates differences between groups compared to control. Different letter indicates differences between treatments; P ≤ 0.05, ANOVA test, followed by aTukey’s post hoc test.